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Summary
Platelets are specialized hemostatic cells that circu-
late in the blood as anucleate cytoplasts. We report
that platelets unexpectedly possess a functional spli-
ceosome, a complex that processes pre-mRNAs in
the nuclei of other cell types. Spliceosome compo-
nents are present in the cytoplasm of human mega-
karyocytes and in proplatelets that extend from mega-
karyocytes. Primary human platelets also contain
essential spliceosome factors including small nuclear
RNAs, splicing proteins, and endogenous pre-mRNAs.
In response to integrin engagement and surface re-
ceptor activation, platelets precisely excise introns
from interleukin-1 pre-mRNA, yielding a mature mes-
sage that is translated into protein. Signal-dependent
splicing is a novel function of platelets that demon-
strates remarkable specialization in the regulatory
repertoire of this anucleate cell. While this mecha-
nism may be unique to platelets, it also suggests pre-
viously unrecognized diversity regarding the func-
tional roles of the spliceosome in eukaryotic cells.
Introduction
Gene expression in nucleated cells is regulated at sev-
eral checkpoints. A critical step is the removal of non-
coding introns from newly transcribed pre-mRNAs, a
process that occurs cotranscriptionally in the nucleus
by a trans-acting complex termed the spliceosome
(Maniatis and Reed, 2002). The human spliceosome
contains small nuclear ribonucleoproteins (snRNPs)
and auxiliary proteins that impart the correct architec-
ture necessary for proper intron recognition and exci-*Correspondence: andy.weyrich@hmbg.utah.edu
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8Present address: Invitrogen Incorporation, 1610 Faraday Avenue,
Carlsbad, California 92008.
9Present address: Lerner Research Institute, NC-10, Cleveland,
Ohio 44195.sion (Maniatis and Reed, 1987). Splicing ensures that
mature, translatable mRNAs are available for export to
the cytoplasm. Observations to date indicate that the
spliceosome operates within nuclear boundaries (Ma-
niatis and Reed, 2002); a functional role for this com-
plex in extranuclear domains has not been described.
Megakaryocytes and their progeny, circulating anu-
cleate platelets, are highly specialized mammalian cells
that participate in hemostatic and inflammatory func-
tions (Weyrich et al., 2003). Presumably, the spliceosome
is critically active in megakaryocytes where regulated
mRNA expression, together with a host of other pro-
cesses, is required to produce functional platelets.
Megakaryocyte differentiation occurs in the bone mar-
row and involves two distinct stages. Commitment of
the hematopoietic progenitor cell to the first stage is
characterized by an arrest of proliferation and initiation
of endomitosis, a process involving several cycles of
genome replication without cell division that results in
diploid chromosome numbers that range from 16N to
128N (Ravid et al., 2002). The second stage of matura-
tion is associated with rapid cytoplasmic expansion
and robust transcription that drives the expression of
genes essential for megakaryocyte maturation, organ-
elle and granular formation, and the development of
specialized proplatelet extensions that eventually
spawn individual platelets that circulate in the blood
(Hartwig and Italiano, 2003). Although transcriptional
processes are regnant during megakaryocyte differenti-
ation, the spliceosome and splicing events have not
been characterized during megakaryopoiesis or throm-
bopoiesis.
Here we explored intracellular distribution patterns in
a model of human megakaryocyte differentiation and
proplatelet formation and found that critical spliceoso-
mal components are present in the cytoplasm of these
cells. Parallel analysis of primary human platelets dem-
onstrated that the net result is the accumulation of
essential spliceosomal proteins and small nuclear ribo-
nucleic acids (snRNAs) in these anucleate cytoplasts.
In addition, mature human platelets isolated from pe-
ripheral blood retain a subset of pre-mRNAs, and we
characterized one of these, interleukin-1β (IL-1β), and
found that it is spliced into mature message in response
to cellular activation. This splicing event coincides with
new synthesis of IL-1β protein and was recapitulated in
an ex vivo splicing system. These unexpected results
indicate that functional spliceosomal components are
distributed to platelets during thrombopoiesis and that
splicing can proceed in response to outside-in signals
in an environment that is devoid of direct nuclear regu-
lation and transcription.
Results
Megakaryocytes, Proplatelets, and Mature Platelets
Contain Critical Splicing Factors
Although mature platelets are anucleate, we discovered
that they retain and splice endogenous pre-mRNAs
Cell
380(see below). Therefore, we hypothesized that critical
spliceosome components accumulate in proplatelets s
during thrombopoiesis, the formation of blood plate- t
lets, and are subsequently maintained in circulating t
platelets after their release from the bone marrow. To (
explore this possibility, we first developed a model of t
human proplatelet formation that mimics the in vivo f
process. Megakaryocytes develop from marrow plu- k
ripotent hematopoietic stem cells, and megakaryo- a
poiesis involves regulated cytoplasmic expansion and p
biogenesis of organelles, granules, and requisite plate- p
let constituents (Italiano and Shivdasani, 2003). In mu- p
rine systems, the megakaryocyte cytoplasm eventually b
undergoes a massive reorganization into beaded ex- i
tensions that are referred to as proplatelet chains, M
transforming the megakaryocyte into a residual nucleus l
surrounded by proplatelet processes (Italiano et al., H
1999). Megakaryocyte maturation ends when proplate- t
lets are separated from the cell body. The subsequent 1
dissolution of cytoplasmic bridges that connect pro- S
platelets releases individual platelets into the circula- S
tion (Hartwig and Italiano, 2003). t
Using hematopoietic CD34+ progenitor cells, we de- w
veloped a human model of megakaryocyte differentia- K
tion and proplatelet formation (Figure 1 and M.M.D., m
N.D.T., C.C.Y., F.J.R., T.M.M., K.H.A., G.A.Z., and A.S.W., m
unpublished data). Mature megakaryocytes generated l
in this fashion contain one to three nuclei, approximate
the size of marrow megakaryocytes, and are packed s
with granules, organelles, and ribosomes (Figures 1A t
and 1B). Granules in the CD34+-derived megakaryocyte c
cytoplasm and megakaryocyte proplatelet extensions p
stain positively for P-selectin (data not shown), a key w
constituent of platelet α granules that translocates to q
the surface membrane during cellular activation (McEver, a
1990). CD34+-derived megakaryocytes also contain a o
rich microtubular network (data not shown) that is criti- S
cal for the cytoskeletal mechanics of platelet biogene- b
sis (Italiano et al., 1999). In addition, megakaryocytes (
and megakaryocytes with proplatelet extensions stain l
positively for αIIb and β3 integrin subunits (Figure 2 and p
data not shown), which heterodimerize to form αIIbβ3 p
integrin, a unique biomarker for cells of this lineage
(Hato et al., 2002). o
Inspection of staining patterns in adherent mega- o
karyocytes, megakaryocytes with proplatelet exten- (
sions, and mature platelets indicate that each cell stage (
contains components of the spliceosome (Figures 1C
e
and 2). This was unexpected because platelets are cy-
h
toplasts and are generally thought to be devoid of
nnuclear constituents. We initially examined U1 70K pro-
1tein, a component of the U1 snRNP (Ruby and Abelson,
i1988). U1 70K is essential for incorporation of the U1
tsnRNP and SF2/ASF into a complex with pre-mRNAs
pthat is required for pre-mRNA processing (Kohtz et al.,
31994). U1 70K protein has at least one defined nuclear
ulocalization signal and is rapidly transported to the nu-
ocleus when it is overexpressed in cell lines (Romac et
pal., 1994). Endogenous U1 70K protein is also confined
3to the nucleus in HeLa cells (data not shown), the prin-
cipal cell line used to characterize the human spliceo-
Psome (Zhou et al., 2002a). U1 70K protein is present in
othe nucleus as well as the cytoplasm of megakaryo-
Icytes and in proplatelets that extend from megakaryo-cytes (Figure 1C).In addition to U1 snRNP binding at the 5# splice site,
pliceosome assembly involves interactions between
he U2 snRNP auxiliary factor (U2AF) and pyrimidine
racts at the 3# splice site of the target pre-mRNA
Graveley et al., 2001). U2AF is a heterodimer that con-
ains 65 and 35 kDa subunits (Graveley et al., 2001). We
ound U2AF65 in the nucleus and cytoplasm of mega-
aryocytes (Figure 2A, top panels). U2AF65 protein is
lso present in proplatelet extensions (Figure 2A, lower
anels) and in mature, human platelets (Figure 2C, top
anels). We also found that megakaryocytes and pro-
latelets contain serine-arginine-rich (SR) family mem-
ers, proteins that stabilize U1 SnRNP and U2AF bind-
ng at the 5# and 3# splice sites, respectively (Wu and
aniatis, 1993). Splicing requires the presence of at
east one member of the SR family (Black, 2003), and
eLa cell S100 extracts do not splice pre-mRNAs due
o limiting amounts of SR proteins (Mayeda and Krainer,
999). The SR family includes members such as SRp20,
Rp30c, 9G8, SRp40, SRp55, SRp70, SF2/ASF, and
C35 (Black, 2003). We focused on SF2/ASF, a proto-
ypic SR protein that regulates constitutive splicing as
ell as some alternative splicing events (Hastings and
rainer, 2001). We found SF2/ASF in the cytoplasm of
egakaryocytes and in proplatelets that extend from
egakaryocytes as well as in mature, circulating plate-
ets (Figure 2B and 2C).
In further analyses, we also detected additional
pliceosomal factors in these cells. The SR-related pro-
ein SRm160 that coactivates pre-mRNA splicing (Blen-
owe et al., 1998) is present in quiescent and activated
latelets (Figure S1). Survival motor neuron (SMN),
hich recycles pre-mRNA splicing factors and is re-
uired for pre-mRNA splicing (Pellizzoni et al., 2002), is
lso found in megakaryocytes, proplatelet extensions
f megakaryocytes, and mature platelets (Figure S2).
MN is also important for the biogenesis of snRNPs
ecause it brings together Sm proteins with U snRNAs
Yong et al., 2002). In this regard, SmBB# and SmD1 are
ocalized in the cytoplasm of megakaryocytes, pro-
latelets that extend from megakaryocytes, and mature
latelets (Figure S3).
In addition to relying on splicing proteins, assembly
f the spliceosome on pre-mRNA requires base pairing
f U snRNAs with specific domains of the pre-mRNA
Hastings and Krainer, 2001). There are five U snRNAs
U1, U2, U4, U5, and U6), each of which is required for
fficient splicing (Hastings and Krainer, 2001). U snRNAs
ave a unique 5# terminal cap structure containing the
ucleoside 2,2,7-trimethylguanosine (TMG) (Krainer,
988; Will and Luhrmann, 2001). Using an antibody that
s specific for the TMG cap, we detected U snRNAs in
he nucleus and cytoplasm of megakaryocytes and in
roplatelets that extend from megakaryocytes (Figure
A). Consistent with this finding, Northern analysis
sing RNA from mature human platelets revealed each
f the U snRNAs, and immunostaining confirmed that
rimary circulating platelets contain U snRNAs (Figures
B and 3C).
re-mRNAs Are Found in Proplatelet Extensions
f Megakaryocytes and in Circulating Platelets
n mature circulating platelets, translation of specific
mRNAs including the cytokine interleukin-1β (IL-1β) is
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381Figure 1. U1 70K Protein Is Localized in the
Cytoplasm of Megakaryocytes and in Pro-
platelets that Extend from Megakaryocytes
(A) Scanning electron micrographs of a CD34+
stem-cell-derived megakaryocyte (left panel)
and a megakaryocyte with proplatelet exten-
sions (right panel). The white arrows in the
right panel point to proplatelets, while the blue
arrow indicates the cell body.
(B) Transmission electron micrographs of a
megakaryocyte (top left panel) and a mega-
karyocyte with a proplatelet extension (top
right panel). The arrow in the top panel is
pointing to the proplatelet extension. The
bottom left panel is a corresponding photo-
micrograph of the megakaryocyte taken at a
higher magnification to identify the nuclear
membrane. The bottom middle and right
panels are corresponding photomicrographs
of the megakaryocyte with a proplatelet ex-
tension taken at higher magnifications to
identify the nuclear membrane. The black ar-
rows in the bottom panels identify the nu-
clear envelope.
(C) A representative megakaryocyte and a
megakaryocyte with proplatelet extensions
were costained with an anti-U1 70K antibody
(green) and wheat germ agglutinin (WGA;
red), a fluorescent lectin that binds cell
membranes and granules. In the megakaryo-
cyte, U1 70K protein is detected in the cyto-
plasm (white arrow in the top, right panel) as
well as in the nucleus. U1 70K protein is also
observed in proplatelet extensions of the
megakaryocyte (white arrows in the bottom,
right panel). The right panels are merged
images of WGA and U1 70K protein. The
blue arrow in the bottom panel indicates U1
70K staining in the nucleus. The photomicro-
graphs in this figure are representative of
three independent experiments.repressed until the cells are appropriately stimulated
(Lindemann et al., 2001a). Although the pathways that
govern translation of IL-1β mRNA are incompletely de-
fined, there is evidence that IL-1β gene expression is
regulated at the level of pre-mRNA processing (Jarrous
and Kaempfer, 1994) and at translational control sites
(Lindemann et al., 2001a). In studies of IL-1β pre-mRNAprocessing, ribonuclease protection assays demon-
strated that intron one in the 5#-untranslated region
(UTR) is a primary area of regulation (Jarrous and
Kaempfer, 1994). Because IL-1β is a regulated product
of activated human platelets (Lindemann et al., 2001a),
we sequenced the 5#-UTR of the IL-1β transcript in cir-
culating platelets and found that the dominant product
Cell
382Figure 2. Critical Spliceosome Factors Are
Present in the Cytoplasm of Megakaryo-
cytes, in Megakaryocytes with Proplatelet
Extensions, and in Circulating Platelets
(A and B) Megakaryocytes were stained with
an anti-U2AF65 (A) or anti-SF2/ASF (B) and
an antibody against the integrin αIIb subunit.
Low-magnification photomicrographs for
each factor are shown in grayscale. The
merged photomicrographs in the right pan-
els are higher magnifications of the areas
outlined in blue in the middle panels. In the
right panels, U2AF65 and SF2/ASF immuno-
localization is shown in green, and αIIb
immunostaining is in red. The white arrows in
the top panels indicate cytoplasmic staining
and in the bottom panels identify immuno-
staining in proplatelet extensions.
(C) Platelets were left in suspension (quies-
cent) or allowed to adhere and spread on im-
mobilized fibrinogen in the presence of
thrombin for 30 or 60 min. The platelets were
stained with antibodies against U2AF65 (top
panels) or SF2/ASF (bottom panels) and the
αIIb integrin subunit (U2AF65 and SF2/ASF
immunolocalization, green; αIIb immuno-
staining, red). Controls for antibody specific-
ity were performed (see Figure 3C for exam-
ples). Cellular spreading on immobilized
fibrinogen in the presence of thrombin de-
monstrates that the platelets were efficiently
stimulated. U2AF65 and SF2/ASF were also
detected in platelets by Western blotting
(data not shown). The images in this figure
are representative of three independent
studies.contains introns one and two, whereas the 3#-UTR i
mproduct is a consensus sequence (Figure S4, top
panel). In contrast, we only amplified exonic sequences Sn the 5# and 3# regions of the transcript for αIIb, an
RNA unique to megakaryocytes and platelets (Figure
4, bottom panel).
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383Figure 3. Localization of U snRNAs in Megakaryocytes, Megakaryocytes with Proplatelet Extensions, and Circulating Platelets
(A) Localization of U snRNAs in a megakaryocyte (left panel) and a megakaryocyte with a proplatelet extension (right panel) was characterized
with an anti-TMG antibody. Staining of U snRNAs and the αIIb integrin subunit are shown in green and red, respectively (blue arrows, nuclear
localization of U snRNAs; white arrows, cytoplasmic localization of U snRNAs).
(B) Northern analysis of U snRNAs (U1, U2, U4, U5, and U6) in HeLa cells and circulating platelets (Plt). The two panels on the right are
Northern blots conducted in the presence of competing unlabeled oligonucleotides demonstrating the specificity of the U snRNA probes.
(C) The top panels are control studies of circulating platelets (left and middle panels) and HeLa cells (right panel), respectively. In the platelet
controls, the cells were incubated with nonimmune mouse IgG and a specific antibody against the αIIb integrin subunit (red stain). The HeLa
cells (top right panel) were costained with anti-TMG (green stain) and phalloidin (red stain), a marker specific for polymerized actin. In the
bottom panels, an anti-TMG antibody (green) was used to localize U snRNAs in quiescent platelets (bottom left panel) and platelets adherent
to immobilized fibrinogen in the presence of thrombin for 30 (bottom middle panel) or 60 (bottom right panel) min. Staining for αIIb is in red.
Each panel in this figure is representative of three independent experiments.
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384Because our RACE data demonstrated that mature r
splatelets contain IL-1β pre-mRNA, we asked if IL-1β
pre-mRNA is localized to the cytoplasm of megakaryo- 1
mcytes that are beginning to extend proplatelets. We
found amplified intronic IL-1β cDNA in the cytoplasm of W
uthese platelet precursors employing probes that detect
introns 1, 4, and 6 (Figure 4A, top panels). We also t
pfound pre-mRNA for IL-1β in quiescent platelets (Figure
4B, top left panel) and mature mRNA for IL-1β in plate- o
alets activated by adhesion to fibrinogen in the presence
of thrombin (Figure 4B, top middle and right panels). g
pNo signal was seen when reverse transcriptase was
eliminated from the RT reactions, establishing specific- r
tity of each assay (Figures 4A and 4B, bottom panels).
a
mActivated Platelets Splice Constitutive Pre-mRNAs
IThe presence of intronic sequences in the mRNA from
aresting platelets, which contain little or no IL-1β protein
2(Lindemann et al., 2001a), implied that activated plate-
nlets may use their splicing machinery to process IL-1β
tpre-mRNA into a translatable, intronless message. To
test this postulate, we designed primers that flanked
Pintron one of the IL-1βmessage and performed RT-PCR
Pusing RNA isolated from highly purified platelet prepa-
Trations depleted of CD45-positive cells to ensure re-
tmoval of any residual leukocytes (see Figure S5). As an
(additional measure, we treated the purified platelets
lwith actinomycin D, a reagent that blocks transcription
tof pre-mRNAs (Lindemann et al., 2004). We found that
hthe dominant IL-1β RNA product in quiescent platelets
acontains intron one (Figure 5A, top panel). We also de-
stected trace amounts of spliced message in quiescent
lplatelets, a finding that varied among experiments and
bmay be due to a low level of ex vivo cellular activation
g(H.S., G.A.Z., A.S.W., N.D.T., unpublished data). In con-
ntrast, in stimulated platelets, IL-1β pre-mRNA is de-
qcreased and the intronless message is correspondingly
cincreased in a time-dependent fashion (Figure 5A, top
opanel), consistent with in situ detection of mature IL-1β
rmRNA in activated, adherent platelets (see Figure 4B,
stop middle and right panels). TA cloning and sequenc-
wing revealed that this processed mRNA is mature, IL-1β
tmRNA (data not shown). The CD45+ leukocytes ex-
ttracted from this platelet preparation contained mature
dtranscripts for CXCL8 (interleukin-8), a leukocyte-spe-
6cific gene product (Lindemann et al., 2004), whereas
lCXCL8 was absent in CD45-depleted platelet prepara-
stions (Figure 5A, bottom panel). In addition, pre-mRNA
tfor IL-1β was not detected in monocytes stimulated
mwith lipopolysaccharide, providing further evidence that
tIL-1β pre-mRNA is platelet derived (Figure S6). CD45
pdepletion, actinomycin D pretreatment, and the ab-
ssence of CXCL8 message in platelet RNA preparations
fargue against genomic contamination. Nevertheless, to
sensure that we did not amplify genomic DNA, we
treated platelet RNA with RNase, a regimen that elimi-
nated IL-1β pre-mRNA and mature mRNA (Figure 5B). D
In contrast, DNase treatment did not alter IL-1β mes-
sage levels in platelets but completely degraded a ge- T
snomic DNA substrate (Figure 5B).
Next, we characterized full-length IL-1β mRNA in n
Tplatelets to confirm that cellular activation generates a
translatable message. We amplified the message under aesting and activated conditions using primers that
pan each intron separately since platelet-derived IL-
β mRNA is in low abundance, a feature of eukaryotic
RNAs under regulatory control (Kochetov et al., 1998;
eyrich et al., 2004). We found that the pre-mRNA in
nstimulated platelets contained all six introns, al-
hough introns 4–6 are partially spliced (Figure 5C, left
anel). Following cellular activation, only trace amounts
f pre-mRNAs remain, whereas the spliced products
re present (Figure 5C, right panel). Consistent with the
eneration of mature message, we found that IL-1β
rotein accumulates in activated platelets (Figure 5D,
ight panel). In contrast, quiescent platelets do not con-
ain IL-1β protein (Figure 5D, left panel). IL-1β protein
ccumulation also parallels regulated translation of the
RNA by platelets embedded in fibrin-rich clots where
L-1β protein is synthesized in sufficient quantities to
ctivate human endothelial cells (Lindemann et al.,
001a). This establishes physiologic relevance for sig-
al-dependent processing of IL-1β pre-mRNA and
ranslation of mature IL-1β mRNA.
latelet Extracts Splice In Vitro-Transcribed
re-mRNA
he human spliceosome has been extensively charac-
erized in vitro using nuclear extracts from HeLa cells
Zhou et al., 2002a; Zhou et al., 2002b). Many other cell
ines fail to yield active nuclear preparations, and in vi-
ro splicing assays have not been developed in primary
uman cells (Mayeda and Krainer, 1999). In our initial
ttempts, we found that crude platelet extracts did not
plice exogenous IL-1β pre-mRNA (Figure 6C, first
ane). In addition, whole-cell extracts from platelets
locked splicing by HeLa cell nuclear extracts, sug-
esting that unstimulated platelets have an endoge-
ous inhibitor (or inhibitors) that silences splicing in
uiescent cells (data not shown). Since intracellular lo-
alization patterns for U1 70K protein (Figure 6A) and
ther splicing factors (Figures 2C and 3C) change in
esponse to activation, we postulated that the platelet
pliceosome may be partitioned to specific regions
ithin the cell. Therefore, we fractionated platelet ex-
racts on stepped sucrose gradients to begin purifying
he spliceosome. We found that U1 70K protein is pre-
ominantly found in fractions two through four (Figure
B) and that fraction four generates a definitive intron-
ess IL-1β message from the intron-containing precur-
or (Figure 6C). TA cloning and sequencing confirmed
hat the spliced product was indeed intronless IL-1β
RNA, and side-by-side comparisons demonstrated
hat it was not amplified from endogenous IL-1β mRNA
resent in fraction four of the platelet lysate (data not
hown). The isolation of splicing-competent extracts
rom platelets confirms that this anucleate cell pos-
esses a functional spliceosome.
iscussion
he human spliceosome is requisite for gene expres-
ion because it removes nontranslatable introns from
ewly transcribed pre-mRNAs (Maniatis and Reed, 2002).
he spliceosome functions within nuclear boundaries,
nd there has been no indication that splicing takes
Signal-Dependent Splicing in Anucleate Platelets
385Figure 4. IL-1β Pre-mRNA Is Present in Developing Proplatelets as well as Quiescent Platelets, and Mature IL-1β mRNA Is Present in Acti-
vated Platelets
(A) In situ PCR for intronic IL-1β mRNA was conducted as described in detail in the Experimental Procedures. The top panels illustrate assays
using probes for introns 1, 4, and 6 and demonstrate that IL-1β pre-mRNA is present in the cytoplasm of CD34+-derived megakaryocytes that
are in the process of extending proplatelets. The black arrows identify cytoplasm of the megakaryocytes. The bottom panels illustrate
corresponding negative controls in which reverse transcriptase was eliminated from the RT reaction (No RT). Here, the black arrows point to
unstained megakaryocytes.
(B) In situ PCR for IL-1β pre-mRNA and mature mRNA was conducted in quiescent platelets (top left panel) and in platelets adherent to
fibrinogen in the presence of thrombin for 1 hr (top middle and right panels), respectively. The far right photomicrographs of adherent,
activated platelets are taken at a higher magnification. In the bottom panels (No RT), the reverse transcriptase was omitted during the RT
reaction. This figure represents inspection of multiple fields from three independent experiments.
Cell
386Figure 5. Activated Platelets Splice Endogenous IL-1β Pre-mRNA into Mature Message and Translate the mRNA into Protein
(A) mRNA levels in platelets that were left quiescent (lane 1) or adhered to fibrinogen in the presence of thrombin (lanes 2–4). Lane 5 identifies
mRNA levels in the CD45+ fraction extracted from this platelet preparation. On the right-hand side, the boxes represent exon 1 and 2 of the
IL-1β message, which flank intron 1 (solid line).
(B) In the left panel, mRNA from platelets that were left quiescent (0) or activated by fibrinogen and thrombin for 30 min was left unmanipulated
(control) or treated with RNase or DNase. The right panel depicts genomic DNA treated with DNase and RNase.
(C) Analysis of IL-1β pre-mRNA and mature mRNA in quiescent platelets and in platelets activated by adherence to fibrinogen for 2 hr in the
presence of thrombin. The IL-1β gene is depicted in the top portion of this figure where exon flanking primer sets are color coded to indicate
the approximate location of individual PCR reactions that span each intron of the IL-1β gene. On the right side, the boxes represent undesig-
nated exons flanking a representative intron to illustrate the patterns of PCR products.
(D) Polymerized actin (red) and IL-1β protein (green) were stained in quiescent platelets and in platelets 8 hr after they adhered to fibrinogen
in the presence of thrombin (Activated). IL-1β protein was detected in adherent platelets consistent with de novo synthesis of the protein by
platelets that are activated by fibrinogen and thrombin (Lindemann et al., 2001a).
Signal-Dependent Splicing in Anucleate Platelets
387Figure 6. Platelet Extracts Splice In Vitro-
Transcribed IL-1β pre-mRNA
(A) This panel demonstrates immunolocali-
zation of U1 70K protein in mature platelets.
In the top panels, fixed platelets were incu-
bated with nonimmune goat IgG and the an-
tibody against the αIIb integrin subunit (red
stain). In the subsequent panels, low-magni-
fication (middle row) and high-magnification
(bottom row) photomicrographs illustrate
platelets that were costained with antibodies
directed against U1 70K protein (green) and
αIIb (red). Each panel is representative of six
independent experiments.
(B) Platelet lysates were left unfractionated
(total plts) or were separated into six frac-
tions on sucrose gradients. U1 70K protein
was detected by Western analysis.
(C) In vitro-transcribed IL-1β pre-mRNA was
incubated with unfractionated platelet ly-
sates (total plts), fractions 1–6, without plate-
let lysates (unspliced control) or with HeLa
cell nuclear extracts (last lane). In vitro-tran-
scribed intronless IL-1β mRNA (spliced con-
trol) was analyzed on the same gel as a posi-
tive control for spliced message. Gels in
Figures 6B and 6C are representative of
three independent experiments.place in the extranuclear milieu of mammalian cells.
Here we demonstrate that platelets, anucleate cyto-
plasts that regulate thrombosis and inflammation, pos-
sess essential splicing factors that process residentpre-mRNAs in response to external cues. Collectively,
these data point to new concepts not formerly consid-
ered. From a general perspective, they identify a novel
mode of nuclear-independent gene expression whereby
Cell
388eukaryotic cells can rapidly alter their message profile v
in response to exogenous stimulation. In the case of g
megakaryocytes, these data also indicate that splicing a
can be uncoupled from transcription and that pre- d
mRNAs are distributed to the cytoplasm by mecha- a
nisms that are yet to be defined. They also demonstrate t
that megakaryocytes distribute functional nuclear con- p
stituents to platelets during thrombopoiesis, an unprec- c
edented finding since platelets are specialized anucleate t
cells. Signal-dependent splicing provides platelets with f
a novel mechanism to alter their pool of translatable s
messages, an important mode of gene regulation that s
expands the recently discovered capacity of this cell to d
translate a subset of mature mRNAs into biologically h
relevant proteins in response to cellular activation (Bro- t
gren et al., 2004; Lindemann et al., 2001a; Weyrich et m
al., 1998). c
Splicing of eukaryotic precursor messenger RNAs m
(pre-mRNAs) involves the excision of introns from the T
pre-mRNA and ligation of flanking exons to produce a r
mature, translatable mRNA (Maniatis and Reed, 2002). m
Splicing is controlled by the spliceosome, a complex b
that is composed of five small ribonucleoproteins n
(snRNP), and each snRNP contains a small nuclear l
RNA (snRNA) and several proteins (Zhou et al., 2002a). i
There are also numerous auxiliary proteins that function f
cooperatively with U snRNPs to process pre-mRNAs o
(Black, 2003; Zhou et al., 2002a). Although the exact u
makeup of the platelet spliceosome is not completely b
defined, our observations demonstrate that platelets
possess functional splicing components when assays i
similar to those used with model cell lines are em- f
ployed (Mayeda and Krainer, 1999). At a minimum, w
platelets contain endogenous pre-mRNAs, all of the U t
snRNAs, and other requisite splicing factors (U1 70K t
protein, U2AF65, SF2/ASF, SRm160, SMN, SmBB#, and q
SmD1). O
In quiescent platelets, translation of mature mRNAs n
such as B cell lymphoma 3 and IL-1β is repressed until t
the cells are appropriately stimulated (Lindemann et al., d
2001a; Weyrich et al., 1998). Pre-mRNA splicing in c
platelets is likewise signal dependent, held in check un- n
til the cell is stimulated. Previous reports indicate that s
extracellular cues regulate alternative splicing in nucle-
ated cells, suggesting that outside-in signals are recog-
c
nized by intracellular splicing effectors (Matter et al.,
m2002; Xie and Black, 2001). However, these signaling
(events occur at the transcription phase as pre-mRNAs
bare spliced into mature messages. In contrast, the
amechanisms we identified in platelets involve signaling
kto post-transcriptional checkpoints. While signal-depen-
tdent extranuclear splicing may be a unique feature of
cplatelets, it is possible that cytoplasmic pre-mRNA
isplicing may also occur in cells such as neurons. Neu-
oronal outgrowth resembles proplatelet morphogenesis
b(Italiano and Shivdasani, 2003), and posttranscriptional
mgene expression can be spatially localized to synaptic
pjunctions (Martin, 2004).
iIn addition to being transcribed but not spliced, IL-
t1β pre-mRNA is distributed to the cytoplasm of mature
nmegakaryocytes so it can eventually be packaged into
kplatelets. This finding was unexpected because, if in-
ttrons are not excised from mRNAs, the transcripts are
generally thought to be degraded in the nucleus, an in nivo safeguard that prevents unwarranted translation of
ene products that jeopardize cellular function (Reed
nd Magni, 2001). Although the mechanisms remain un-
efined, megakaryocytes and platelets have developed
system that circumvents this regulatory feature in a
ranscript-selective fashion. In addition to the IL-1β
re-mRNA, we found that other intronic messages are
aptured by trimethylguanosine immunoprecipitates in
hese cells. Some of these pre-mRNAs include tissue
actor and high-mobility group box 1 (HMGB1) (data not
hown). Both tissue factor and HMGB1 pre-mRNAs are
pliced into mature messages by platelets in a signal-
ependent fashion (our unpublished data). Several studies
ave recently demonstrated that quiescent platelets re-
ain a surprisingly large set of megakaryocyte-derived
RNAs that are stably expressed, diverse, and in some
ases translatable (Bahou and Gnatenko, 2004; Linde-
ann et al., 2001a, 2001b; McRedmond et al., 2004).
hese analyses are largely based on standard microar-
ay procedures that are not optimized to detect intronic
essages; therefore, message profiles in platelets may
e more extensive and diverse than previously recog-
ized. Further characterization of the portfolio of plate-
et pre-mRNAs may reveal additional patterns of splic-
ng into predicted or alternative messages that code
or inflammatory and thrombotic proteins. Additionally,
nly subsets of platelet messages contain introns (Fig-
re S4), indicating differential handling and the possi-
ility of novel forms of selection in megakaryocytes.
Identification of a functional spliceosome in platelets
ndicates that megakaryocyte nuclei may influence
unctional responses of mature circulating platelets in
ays not previously considered. The prevailing tenet is
hat polyploid megakaryocyte nuclei serve as transcrip-
ion factories to facilitate increases in cell mass re-
uired to assemble hundreds of individual platelets.
ur observations demonstrate that essential compo-
ents of the megakaryocyte spliceosome are also dis-
ributed to platelets during thrombopoiesis, altering
ogma that platelets are devoid of functional nuclear
onstituents (Ravid et al., 2002) and providing a mecha-
ism for regulated modification of the platelet tran-
criptome beyond the stage of proplatelet formation.
The human spliceosome is one of the most complex
ellular machines characterized so far, consisting of
ore than 100 proteins and specialized nuclear RNAs
Zhou et al., 2002a). Possession of such a daedal unit
y platelets demonstrates remarkable specialization
nd intricate information distribution from the mega-
aryocyte to the terminally differentiated platelet. Whether
he spliceosome is translocated out of the megakaryo-
yte nucleus by regulated nuclear export or, in contrast,
s differentially localized to the cytoplasm by inhibition
f nuclear import is not known. Passive movement via
reaks in the nuclear envelope is also possible because
egakaryocytes undergo endomitosis to become poly-
loid, a process that weakens the nuclear envelope as
t disassembles and reassembles with each endomi-
otic cycle (Italiano and Shivdasani, 2003). However, the
uclear envelope is ultrastructurally intact in mega-
aryocytes with proplatelet extensions (Figure 1B). Fur-
hermore, spliceosomal components are found in the
ucleus throughout proplatelet formation, suggesting
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389that splicing factors do not leak into the cytoplasm in
an uncontrolled fashion.
Eukaryotic cells use a variety of gene expression
mechanisms to diversify and increase their proteomes.
One level of control occurs at pre-mRNA splicing, a
step that heretofore has been structurally and function-
ally associated with the nucleus. Our demonstration
that pre-mRNA splicing can also occur in an environ-
ment devoid of a nucleus, the cytoplasmic milieu of ac-
tivated human platelets, identifies an important exten-
sion of the regulatory repertoire of eukaryotic cells. In
addition, it establishes additional diversity in the func-
tional properties and capability for phenotypic alter-
ation in this remarkable, specialized blood cell.
Experimental Procedures
Cells
CD34+ progenitor cells were isolated from umbilical cord blood
(IRB# 11919). The CD34+ cells were cultured in suspension with X
Vivo-20 culture medium (BioWhittaker, Walkersville, Maryland) that
contained 50 ng/ml of thrombopoietin (Chemicon International,
Inc., Temecula, California) and 40 ng/ml of human stem cell factor
(Biosource, Camarillo, California). At day 13, the cells were placed
on immobilized human fibrinogen (Calbiochem-Novabiochem Cor-
poration, San Diego, California) to sort mature megakaryocytes ca-
pable of forming proplatelets over a 16 hr incubation period
(M.M.D., N.D.T., C.C.Y., F.J.R., T.M.M., K.H.A., G.A.Z., and A.S.W.,
unpublished data).
Washed human platelets were isolated using methods that we
have previously described (Weyrich et al., 1996), with the exception
that contaminating leukocytes were always removed by CD45+
bead selection at the PRP stage. We were unable to detect any
residual leukocytes in CD45-depleted preparations by hemocytom-
eter counting and microscopy (Figure S5, middle panel); however,
platelet counts were normally reduced by 20%–40%. The nega-
tively selected platelets were resuspended in M199 serum-free cul-
ture medium for all studies (Lindemann et al., 2001a). The cells
were either left quiescent or allowed to adhere to immobilized hu-
man fibrinogen (Calbiochem, La Jolla, California) in the presence
of thrombin (0.05 U/ml; Sigma).
Human monocytes were isolated by countercurrent elutriation as
previously described (Weyrich et al., 1996). HeLa S3 (CCL-2.2,
ATCC) cells were grown in suspension using spinner flasks, and
HeLa (CCL-2, ATCC) cells were grown on coverglass chamber
slides (Nalge Nunc International Inc., Naperville, Illinois) in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with
10% FBS.
mRNA Detection Systems
RACE
Total platelet RNA was used to generate first-strand RACE-ready
cDNA (Clontech, Palo Alto, California). Gene-specific primers for
5#-RACE were directed to exon 3 and exon 1 for IL-1β and αIIb,
respectively. Gene-specific primers for 3#-RACE were directed to
exon 7 and exon 25 for IL-1β and αIIb, respectively. RACE products
were sequenced on an ABI3730 96-capillary sequencer (Applied
Biosystems, Foster City, California) using M13R and M13F primers.
Exon-Flanking RT-PCR
Studies to determine endogenous splicing in quiescent and acti-
vated platelets were done by PCR using primers flanking intron 1
of IL-1β. PCR for IL-1β was also conducted over each intron of
the gene using primers that targeted flanking exons and conditions
optimal for amplification of longer transcripts (see Figure 5C). In
select studies, platelet RNA was treated with DNase 1 (Ambion Inc.,
Austin, Texas) and RNase 1 (Promega, Madison, Wisconsin) to con-
firm that it was RNA. Parallel controls with in vitro-transcribed RNA
and genomic DNA, isolated from human monocytes, were simulta-
neously analyzed.
Northern Analysis of U snRNAs
Total RNA was isolated from purified human platelets and cultured
HeLa S3 cells as previously described (Weyrich et al., 1998). ForNorthern analysis, oligonucleotide riboprobes to the snRNAs (U1,
U2, U4, U5, and U6) were synthesized using mirVana miRNA Probe
Construction Kit (Ambion Inc., Austin, Texas). The probe sequences
were as follows: U1-GAGATACCATGATCACGAAGGCCTGTCTC;
U2-GCTAAGATCAAGTGTAGTATCCCTGTCTC; U4-TGCAATATAGT
CGGCATTGGCACCTGTCTC; U5-GGAACAACTCTGAGTCTTAACC
CTGTCTC; and U6-AGAGAAGATTAGCATGGCCCCCCTGTCTC. Com-
petition studies using cold oligonucleotides directed against each
snRNA probe were done to control for specificity of the hybrid-
ization.
In Situ Detection of mRNAs and U snRNAs
Indirect or direct in situ PCR was used to detect IL-1β mRNA in
megakaryocytes that were forming proplatelets and mature plate-
lets, respectively. For indirect in situ PCR, megakaryocytes that
were developing proplatelet extensions were fixed with 4% para-
formaldehyde and permeabilized with 0.2 M HCl, and endogenous
DNA was removed by DNase treatment. cDNA was generated by
reverse transcription, and then the cDNA was amplified with prim-
ers specific for introns one, four, and six of IL-1β. Negative control
samples received no MMLV reverse transcriptase during cDNA syn-
thesis. After PCR amplification, the cells were refixed, prehybrid-
ized, and then hybridized with 400 ng/ml of their corresponding
intronic DIG-labeled probe. Primers specific for intron one (5#-
CAAGGATCCTGCTCCAGCTCTCCTAGCC-3# and 5#-ACCGGTACC
TGAGTGACTTCCCCATGACG-3#), four (5#-AAAAAGCTTAGGCTGG
AAACCAAAGCAAT-3# and 5#-AGCGGATCCTGGGGTGGCTAAGA
ACACTG-3#), and six (5#-CCAAAGCTTGGAAAAGCTGGGAACAG
GTC-3# and 5#-GAAGGATCCGCTGAGAAAGCTGGAGGTGA-3#) were
used to generate the DIG-labeled probes. After a series of wash
steps, an anti-DIG alkaline peroxidase (anti-DIG-AP) antibody was
incubated with each sample, and hybridized signals were detected
with an NBT/BCIP colorimetric reaction (Roche Applied Science,
Penzberg, Germany).
For direct in situ PCR analysis, platelets were fixed with paraform-
aldehyde, permeabilized, and treated with DNase as described
above. In each study, the initial cDNA template was generated by
reverse transcription, and then endogenous RNA was removed
using RNase ONE. This step was critical to reduce background be-
cause we found that DIG-labeled dNTPs bind with high efficiency
to endogenous RNA in platelets (data not shown). After RNase
treatment, the cDNA generated in quiescent platelets was ampli-
fied in the presence of DIG-labeled dNTPs using primers specific
for intron one (5#-CAAGGATCCTGCTCCAGCTCTCCTAGCC-3# and
5#-ACCGGTACCTGAGTGACTTCCCCATGACG-3#). In the case of
adherent platelets, the cDNA was amplified in the presence of DIG-
labeled dNTPs using primers that targeted exons one (5#-CGAGG
CACAAGGCACAACAG-3#) and four (5#-GCATCTTCCTCAGCTTG
TCC-3#), respectively. These exonic primers allowed us to detect
the spliced product (307 bp), but not the intronic product (3326 bp),
by normal PCR methods. Negative control samples received no
MMLV reverse transcriptase during the initial cDNA synthesis step.
After the cDNA products were amplified in the presence of DIG-
labeled dNTPs, the cells were refixed, and the labeled dNTPs were
detected as described above.
U snRNAs in megakaryocytes, megakaryocytes with proplatelet
extensions, mature platelets, or HeLa cells were detected with an
antibody directed against the 2,2,7-trimethylguanosine cap (Cal-
biochem, La Jolla, California). The methods used to detect U
snRNAs with anti-TMG parallel the procedures described below for
immunocytochemical detection of splicing proteins (see below).
In Vitro Splicing Assay
HeLa nuclear extracts competent for splicing were obtained from
ProteinOne Inc. (College Park, Maryland). Platelet extracts were
isolated using a modified protocol designed for HeLa cells (Mayeda
and Krainer, 1999). In brief, adherent platelets were lysed by nitro-
gen cavitation bombing at 1200 psi for 5 min. The soluble lysate
was placed on a 30%–60% sucrose step gradient made in 20 mM
HEPES (pH 7.9), 20% (v/v) glycerol, 0.42 M NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 0.5 mM PMSF, and 0.5 mM DTT, and the gradient
was centrifuged at 34,900 rpm for 3 hr in a SwTi40 rotor. Six cellular
fractions were collected and used for in vitro splicing experiments.
A cDNA template of IL-1β containing intron one was made, incor-
porating a T3 promoter and poly-A tail, by PCR (forward primer,
AATTAACCCTCACTAAAGGGAGAACCTCTTCGAGGCACA; reverse
Cell
390primer, TTTTTTTTTTTTTTTTTTTTCCTGTAATAAGCCATCATTTCAC). s
FIn vitro-transcribed IL-1β pre-mRNA was mixed with 15 l of plate-
let fractions or HeLa cell nuclear extract, 5 mM HEPES (pH 7.9), 1 a
FmM ATP, 20 mM creatine phosphate, 2 mM MgCl2, 2 mM DTT, 0.2
mM EDTA, and 0.6% (w/v) polyvinyl alcohol (total volume of the t
tmixture = 25 l). The reaction was incubated for 4 hr at 30°C, the
RNA was isolated and reversed transcribed and the cDNA was then
amplified by PCR using primers specific for exon one and two, and
Rthe PCR products were TA cloned and sequenced.
RProtein Detection Systems
AWestern blot and immunocytochemical analysis was conducted as
Ppreviously described (Weyrich et al., 1998). For these studies, anti-
bodies directed against IL-1β (sc-1250), U1 70K protein (sc-9571),
RSRm160 (sc-10990), and αIIb integrins (sc-15328) were from Santa
Cruz Biotechnology (Santa Cruz, California). The antibodies against
ASm BB# and Sm D1 were from Progen (Heidelberg, Germany). The
Panti-SMN antibody was from BD Transduction Laboratories (Lex-
iington, Kentucky), and the antibodies directed against U2AF65 and
ASF2/ASF were from Zymed (San Francisco, California). Specificity
of the immunocytochemistry studies was confirmed by peptide B
quenching of the antibody, parallel studies with nonimmune IgG, or a
deletion of the primary antibody. m
B
Ultrastructural Analyses s
Scanning Electron Microscopy
BMegakaryocytes and proplatelets that extend from megakaryo-
Acytes were fixed for 24 hr with 2.5% glutaraldehyde and 1% para-
Bformaldehyde in 0.1M sodium cacodylate buffer (pH 7.4) for 24 hr.
JThe fixed cells were then rinsed with sodium cacodylate and post-
mfixed with 2% osmium tetroxide, dehydrated with a graded series
of ethanol, and then dried in hexamethyldisalizane. The samples G
were subsequently mounted on colloidal graphite, sputter coated, U
and visualized using a scanning electron microscope (Hitachi 8
S2460 N, San Jose, California). H
Transmission Electron Microscopy T
CD34+ stem-cell-derived megakaryocytes were placed on fibrino-
Hgen-coated acylar for ultrastructural observation. After 1 or 16 hr,
nthe cells were fixed with 2.5% glutaraldehyde/1% paraformalde-
Hhyde in cacodylate buffer followed by postfixation with 1% osmium
ptetroxide, dehydration in a graded acetone series, embedment in
Aresin, and thin sectioning with a diamond knife (Albertine et al.,
1999). A Hitachi H-7100 transmission electron microscope was I
used to observe and photograph the thin sectioned cells. b
I
(
Supplemental Data p
Supplemental Data include six figures and can be found with this J
article online at http://www.cell.com/cgi/content/full/122/3/379/
JDC1/.
k
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